Diabetie nephropathy in type 2 diabetic patients at Lampang Hospital

Main Article Content

Chutima Kanchanawong


Diabetic nephropathy is the most common cause of chronic kidne dieseases, and is associated with increasd cardiovascular mortality. Intensive blood glucose control to achieve HbAle < 7% and blood pressur < 130/80 mm Hg mitigates the incidence of nephordpathy in type 2 diabetic patiens. This study was conducted on 2017 type 2 diabetic patients. The prevalence of miroalbuminuria and macroalbuminuria wer 28.31% and 7.49% respectively. Risk factors contributing to diabetie nephropathy were high blood pressure, blood glucose, and triglycerides, low HDL, cholesterol, advanced age, and long duration of diavetes. The prevanlence of retinopathy was hither in patients with nephorpaty (26.62% with microalbuminuria, and 43.71% with macroalbuminuria). ACEL and ARB were used in most of the patients for blook ressure contro, which 37.53% of the total patients had blood pressure <130/80 mmHg, and 45.76% hsd HbAlc < 7%. ASA was prescribed in 6.57% of the patients with microalbuminuria, and 68.87% with macroalbuminuria, Education doctors and health care providers of desirable metabolic parameters as recommended
by ADA will help in improving diabetic managment, preventing and delaying diabetic complication, and reducing mortality


Download data is not yet available.

Article Details

How to Cite
Kanchanawong, C. . . . (2022). Diabetie nephropathy in type 2 diabetic patients at Lampang Hospital. Lampang Medical Journal, 29(1), 20–29. Retrieved from https://he01.tci-thaijo.org/index.php/LMJ/article/view/259941
Original Article


Valdmadred CT< Klein R, MoSS SE, Klein BE. The risk of cardiovascular disease mortality associated with older-onset diabeted mellitus. Arch Intern Med 2000; 160: 1093-2000.

Zandbergen AA, Lambers SW, Sijbrands EJ, Bootsma AH. Birntensive women with type 2 diabetes and microalbuminuria art at high risk for macrovascular disease. Diabetes Care 2006: 29: 1851-55.

America Diabetes Association. Nephrophathy in diabetes (Position statement). Diabet care 2004, 27(suppl.1) : s79 - s83.

Adler AI, Stevens RJ, Manley SE, Biloes RW, Cull CAm Holana RR. Devevolment and progression of nephorpathy in type 2 diaheres; the United Kingdom Prospective Study (UKPDS 64). Kidney Int 2003; 63: 255-32.

Murussi M, B aglio P, Gross JT, Silveiro SP. Risk factors for microalbuminuria and macroalbuminuria in type 2 diabeted patients : a 9-year follow-up study. Diabetes Care 2002; 25 : 1101-03.

Gali MA, Houtaard P. Borch-Jonhsen K, Parving HH. Riskfactors for development of inciipient and overt diabetic nephropathy in patients eith non-insulin dependent diabetes mellitus: prospective, observational study, BMJ 1997; 314: 783-88.

Stration IM, Adler Al, Neil HA, Mathews DR, Manley SE et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective obervational study. BMJ 2000; 321: 405-12.

Fiorett P, Steffes MW, Sutherland DE, Goetz PF, Mauer M, Reversal of lesions of diabetic nephropathy afer panccreas transplantation.

N Engt J Med 1998; 339: 69-75.

Ravid M, Brosh D, Ravid - Ssfran D, Levy Z, Rachami R. Main risk factors for nephropathy in type 2 diabetes mellitus ane plasma

choesterol tevels, mean blood perssure and thperglycemin, Arch Intell Med 1998; 158: 998-1004.

Nelson RG, Knomler WC, Pettitt DJ, Hanson RL, Bennett PH. Incidents snd determinants of elevated urinary albumin excretion

ine Pima Indians with NIDDM. Diabetes Care 1995. 18: 182-87.

Leitao CB, Boza JC, Canani LH, Pinotti AF, Kramer CK, Gross JL. Masked hypertension, urinary alblumin excretion rate, and

echocardiographic [arameters in putatively mormotensive type 2 diabetic patients, Diabetes Care 2007; 30: 1255-60.

Leitao CB, Canani LH, Bolson PB, Molon MP, Pinotti AF, Gross jL. Urinary albumin excretion rate is associated with increased

ambulatory blood pressure in nomoalbuminuric type , diabetic patients, Diabetes Care 2005; 28: 1724-29.

Sawicki PT, Didjurgeit U, Muthlhauser l, Bender R, Heinemann L, Berger M. Smoking is associated with progression of diabetic

nephropathy. Diabetes Care 1994; 17: 126-31.

Hovind P, Rossing P, Tarnow L, Parving HH. Smoking and progresion of diabetic nephrpathy in type 1 diabetes. Diabetes Care

; 26: 911-16.

Stone ML, Lee JW, Craing ME, Verge CF, Chan AK, Donaghue KC, Natural history and risk factors for microalbumuria in adolescents

with type 1 diabetes : a longitedinal study. Doabeters Care 2006; 29: 2072-77.

Moliteh ME, Rupp D, Carmethon M. Higher levels of HDL cholcstrol are associated with a decreased likelihood of albuminuria in

patients with long standing type 1 diabetes. Diabeted. Diabetes Care 2006; 26:78-82.

UK Propective Diabetes Studey (UKPDS) Group, Intensive blood glucose control with suplphonyluresas or insulin compared with

conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS). Lancet 1998; 352:837-53.

Shichiri M, Kisthikawa H, Ohkubo Y, Wake N. Long - term resullts of the Kumamoto Study on optimal diabetic control in type 2

diabetic patients. Diabetes Care 2000; 23(suppl. 2): B21-B29.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. The Seventh Report of the joint National Commitee oe Precention,

Detection, Evaluation, and treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.

Sasso PC, Salvatore T, Nicola LD, Conte G, Carbonara O, et al. Cardiovascular risk factors and disease managment in type 2 diabetie

patients with diabetic nephropathy. Diabetes Care 2006; 29: 498-503.

Ltndholm LH, Ibsen H, Dahlof B, Deverneus RB, Beevers G, et al. Cardiovascular morbidity and mortality in patients with diabetes ih

the Losartan intevention For Endpoint reduction in hypertenion stydy (LIFE); a randomized trial against atenolol. Lancer 2002; 359:


Ravid M. Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R. Use of enalapril to attenuate deciline in renal function in normotensive,

mormoalbuminuric patients with type 2 diabetes mellitus: a randomized, controlled trial, Ann Intern Med 1998; 218: 982-88.

Heart Outcomes prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular adn microvascular outcomes in

people with deabetes mellitus : results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355:2563-59.

Isbens H, Mogensen CE, Olsen MH, Dahlor B, Wachtell L.et al. Does albuminuria predict cardiovascular outcomes on treament with

lasartan versus atenolol in patients with diabetes, hyperternsion, and left ventricular hypertrophy?. .Diabetes Care 2006; 29: 595-600.

Final report on the aspirin component of the ongoing Physicans' health Study Research Group, N Engl J med 1989; 321: 129-35.

Hayden M, pignone M, Phillips C, Mulrow C, Asprin for the primary prevention of cardiovascular events : a summary of the evidence for

the IS [revemtove Services Task Force. Ann Intern Med 2002l 136L 161-72.

US preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events: necommendation and rationale. Ann Intern

Med 2002; 136-157-60.

Yokoyama H, Kawai K, Kobayashi M : ont behalf of the Japan Diabetes Climical Data Managment Study group. Microalbuminuria is common

in Japanese type 2 diabetic patients : A nationwide survey from the Japan Diabetes Clinical Data Managerment Study group (JDDM 10). Diabetes Care 2007; 30: 989-92.

Ngarmukos C, Bunnag P, Kosachunhanun N, Krittiyaong S, Leelawatana R, et al. Thailand Deiavetes Registry Project: Prevalence, characteristiecs and treatment of patients with diabetic nephropathy. J Med Assoc Thai 2006; 89(suppl 1): s37-42.

Gross JL, Canani LH, Axevedo Mj, Caramori ML, Silverio Sp, Zehmanovitz T. Diabetic nephropathy : Dignosis prevention, and treatment. Diabetes care 2005; 28:164-760

Tatti P, Pahor M, Byington RP, DiMauro P, Guarisco R, et al. Outcome reults of the Fosingpril Versus Amlodipine Cardiovascular Events

Randomized Trial (FACET) in patients with hypertension ans NIDDM. Diabetes Care 1998; 21: 597-603.

Pfeffer MA, Swberg K, Granger CB, Held P, McMurray JJ, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure : the CHARM-Overall programme, Lancet 2003; 362: 759-66.

McAlister FA, Chen Z, Campbell N, Tu K, Hua MD. Antithypertensive medication prescribing in 27, 822 elderly Candians with diaberes over the past decade. Diabetes Care 2006; 29" 836-41.